Paulson Richard A.
SEC CIK 1804460 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | Pres, CEO, Dir | 269.7K | — | $876.0K | 51 | 2022-02-28 | 2026-05-14 |
Most active insiders at KPTI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Paulson Richard A. | Pres, CEO, Dir | — | $137.2K |
| 2 | Poulton Stuart | EVP, Chief Development Off | — | $56.4K |
| 3 | Rangwala Reshma | EVP, Chief Medical Off | — | $55.6K |
| 4 | Cheng Sohanya Roshan | EVP, Chief Commercial Off | — | $46.4K |
| 5 | Mano Michael | SVP, GC, Sec | — | $35.7K |
| 6 | Macomber Lori | EVP, CFO, Treas | — | $10.2K |
| 7 | Abate Kristin | CAO | — | $10.0K |
| 8 | Su Zhen | Dir | — | — |
| 9 | Oliger Christy J. | Dir | — | — |
| 10 | Schor Chen | Dir | — | — |
Transactions 51
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 16:03 | 2026-05-13 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | A - Grant | $0.00 | +4,920 | 271.9K | +2% | $0 | |
| 2026-05-15 16:03 | 2026-05-14 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $9.50 | -2,203 | 269.7K | -0.8% | -$20.9K | |
| 2026-03-03 | 2026-03-02 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $9.41 | -12.4K | 267.0K | -4% | -$116.3K | |
| 2026-02-09 | 2026-02-05 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | A - Grant | $0.00 | +81.1K | 279.4K | +41% | $0 | |
| 2025-10-16 | 2025-10-15 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | A - Grant | $0.00 | +114.3K | 198.3K | +136% | $0 | |
| 2025-09-16 | 2025-09-12 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | A - Grant | $0.00 | +2,800 | 85.3K | +3% | $0 | |
| 2025-09-16 | 2025-09-15 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $6.43 | -1,257 | 84.0K | -1% | -$8,083 | |
| 2025-05-07 | 2025-05-06 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $7.12 | -236 | 82.5K | -0.3% | -$1,680 | |
| 2025-04-07 | 2025-04-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $3.74 | -245 | 82.7K | -0.3% | -$916.30 | |
| 2025-03-06 | 2025-03-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $6.29 | -11.7K | 83.0K | -12% | -$73.6K | |
| D | 2025-03-04 | 2025-02-28 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | A - Grant | $0.00 | +20.0K | 94.7K | +27% | $0 |
| 2025-02-05 | 2025-02-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $0.65 | -4,099 | 1.12M | -0.4% | -$2,664 | |
| 2025-01-07 | 2025-01-06 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $0.78 | -4,055 | 1.12M | -0.4% | -$3,163 | |
| 2024-12-05 | 2024-12-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $0.81 | -3,620 | 1.13M | -0.3% | -$2,932 | |
| 2024-11-06 | 2024-11-05 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $0.91 | -3,675 | 1.13M | -0.3% | -$3,344 | |
| 2024-10-07 | 2024-10-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $0.88 | -3,607 | 1.14M | -0.3% | -$3,174 | |
| 2024-09-05 | 2024-09-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $0.72 | -3,667 | 1.14M | -0.3% | -$2,640 | |
| 2024-08-08 | 2024-08-06 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $0.93 | -3,608 | 1.14M | -0.3% | -$3,355 | |
| 2024-07-09 | 2024-07-05 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $0.85 | -3,616 | 1.15M | -0.3% | -$3,074 | |
| 2024-06-06 | 2024-06-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $0.99 | -3,592 | 1.15M | -0.3% | -$3,556 | |
| 2024-05-07 | 2024-05-06 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $1.13 | -3,576 | 1.15M | -0.3% | -$4,041 | |
| 2024-04-05 | 2024-04-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $1.29 | -3,563 | 1.16M | -0.3% | -$4,596 | |
| 2024-03-06 | 2024-03-05 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $1.30 | -3,573 | 1.16M | -0.3% | -$4,645 | |
| M | 2024-03-04 | 2024-02-29+ | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $1.18 | -99.8K | 1.18M | -8% | -$117.4K |
| 2024-02-29 | 2024-02-28 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | A - Grant | $0.00 | +442.8K | 1.26M | +54% | $0 | |
| 2024-02-08 | 2024-02-06 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $1.59 | -4,012 | 821.5K | -0.5% | -$6,379 | |
| 2024-01-25 | 2024-01-24 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | A - Grant | $0.00 | +42.0K | 825.5K | +5% | $0 | |
| 2024-01-08 | 2024-01-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $0.82 | -4,114 | 783.5K | -0.5% | -$3,373 | |
| 2023-12-05 | 2023-12-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $0.79 | -3,622 | 787.6K | -0.5% | -$2,861 | |
| 2023-11-07 | 2023-11-06 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $0.92 | -3,606 | 791.2K | -0.5% | -$3,318 | |
| 2023-10-05 | 2023-10-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $1.27 | -3,589 | 794.8K | -0.4% | -$4,558 | |
| M | 2023-09-06 | 2023-09-05 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $1.33 | -3,622 | 798.5K | -0.5% | -$4,817 |
| 2023-08-08 | 2023-08-07 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $1.72 | -3,722 | 802.0K | -0.5% | -$6,402 | |
| 2023-07-06 | 2023-07-05 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $1.72 | -3,538 | 805.7K | -0.4% | -$6,085 | |
| 2023-06-07 | 2023-06-05 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $2.24 | -3,536 | 809.3K | -0.4% | -$7,921 | |
| 2023-05-05 | 2023-05-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $3.35 | -3,805 | 812.8K | -0.5% | -$12.7K | |
| 2023-04-05 | 2023-04-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $3.97 | -3,497 | 816.6K | -0.4% | -$13.9K | |
| 2023-03-07 | 2023-03-06 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $3.16 | -3,506 | 820.1K | -0.4% | -$11.1K | |
| 2023-03-02 | 2023-02-28 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | A - Grant | $0.00 | +252.0K | 856.7K | +42% | $0 | |
| 2023-03-02 | 2023-03-01 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $3.03 | -33.0K | 823.6K | -4% | -$100.1K | |
| 2023-02-08 | 2023-02-06 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $3.40 | -3,950 | 604.7K | -0.6% | -$13.4K | |
| 2023-01-05 | 2023-01-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $3.27 | -3,922 | 608.6K | -0.6% | -$12.8K | |
| 2022-12-06 | 2022-12-05 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $5.17 | -3,490 | 612.5K | -0.6% | -$18.0K | |
| 2022-11-08 | 2022-11-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $4.54 | -3,493 | 616.0K | -0.6% | -$15.9K | |
| 2022-10-05 | 2022-10-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $5.87 | -3,488 | 619.5K | -0.6% | -$20.5K | |
| M | 2022-09-09 | 2022-09-08 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $5.23 | -3,479 | 623.0K | -0.6% | -$18.2K |
| 2022-08-05 | 2022-08-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $4.48 | -2,314 | 626.5K | -0.4% | -$10.4K | |
| 2022-07-11 | 2022-07-08 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $5.18 | -2,115 | 628.8K | -0.3% | -$11.0K | |
| 2022-06-08 | 2022-06-07 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $5.76 | -2,542 | 630.9K | -0.4% | -$14.6K | |
| M | 2022-05-05 | 2022-05-04 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $6.23 | -28.5K | 633.4K | -4% | -$177.6K |
| D | 2022-03-02 | 2022-02-28 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Pres, CEO, Dir | A - Grant | $0.00 | +288.8K | 662.0K | +77% | $0 |
Purchase Sale Sale after option exercise All abbreviations